Synonyms: Ro 47-0543
Compound class:
Synthetic organic
Comment: AQ-13 is a 4-aminoquinoline antimalarial compound related to chloroquine [3,7].
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
No information available. |
Summary of Clinical Use ![]() |
AQ-13 has completed a Phase 2 proof of concept study for the treatment of uncomplicated P. falciparum malaria in adults (NCT01614964). The per-protocol analysis of results from this clinical trial indicates that AQ-13 is similarly effective when compared to the approved combination therapy of artemether plus lumefantrine (trade name Coartem®)[6]. |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT01614964 | Studies of a Candidate Aminoquinoline Antimalarial (AQ-13) | Phase 2 Interventional | Tulane University |